Sharing in-house experience across the Association

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Sharing in-house experience across the Association

A new INTA Project Team has been created to help ensure the perspective of in-house practitioners is made available across INTA’s work. The Cross Pollination Project Team, launched this year, is part of the In-House Practitioners Committee and is holding its first face-to-face meeting in Hong Kong this week.

Jomarie Fredericks of Rotary International, Chair of the Committee, says: “A number of Committees want or need in-house input on various issues, so this Project Team will ensure there is a resource already available when that is the case.”

Dolores A. Moro of Kimberly-Clark, one of two leaders of the 10-person team, says the Team is taking “baby steps.” She sees this week as “an opportunity to introduce ourselves and start participating in particular projects with various teams” and says the Project Team will also provide a vehicle for in-house practitioners to develop their roles within Committees and in INTA more generally, thereby enhancing the corporate member experience.

Her co-leader, Diana Ho of PING, adds: “We feel that we’re meeting a need that we noticed was there. Once Committee members get used to us being there, there may be other uses for this Project team too.” She says that the Team can play a unique role in helping Committees understand the challenges and issues facing in-house counsel, as they deal with “real-world” issues every day that require both legal and business advice, ranging from brand protection to enforcement, the internet and globalization. Committee Vice Chair Chris Turk, of The H. D. Lee Company, agrees: “Sometimes as legal practitioners in general we lose sight of what’s important. This Team allows us to provide a check and balance to practice in reality rather than a hypothetical perspective.”

INTA at present has 986 corporate members, about one-third of them outside of the United States. About 20% of the more than 3,000 Committee volunteers work in-house, so there is plenty of scope for cross-pollination. After all, as Moro says, INTA is a brand-owner association: “In-house practitioners definitely can bring a real-time perspective and help people understand the issues that are facing us.”

It’s early days for the Team, but already they have some clear aims. One is to add more expertise from outside the US, to reflect the global membership of INTA. Another is to seek out information from other Committees about how in-house practitioners can help them. “Our role will be defined where other people think we can bring value,” says Fredericks.

more from across site and SHARED ros bottom lb

More from across our site

New platform, which covers SEPs covering the Wi-Fi 6 and Wi-Fi 7 standards, includes 10 patent owners
The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Gift this article